Number of Seats/Users: Randomize.net offers discounts based on the number of users or seats. A higher volume typically leads to a better discount structure, especially for enterprise-level usage.

Commitment to a Long-Term Contract: Discounts are often provided to companies that commit to using the service for a longer period (e.g., 1-year or 3-year contracts). A longer commitment shows Randomize.net that the company is serious and willing to invest in the platform long-term.

No Active Discounts: Companies that are not already receiving other active discounts may have a better chance of qualifying for additional discounts from Randomize.net. Randomize.net reserves discounts for new customers or those not currently under promotional pricing.

Volume or Usage Commitment: Randomize.net offers discounts if you agree to a minimum amount of usage or transaction volume. This could be based on data storage, transactions, or other metrics tied to how much you will use the platform.

Enterprise-Level Negotiation: Companies that qualify as “enterprise” due to their size or complexity (e.g., having large teams, multiple departments, or geographical presence) may be eligible for additional discounts from Randomize.net. Such companies are often in a position to negotiate for better pricing.

Early Renewal or Prepayment: Randomize.net often offers discounts if you renew early or prepay for the entire contract period. This is a common approach to securing a lower price.

At Spendbase, our internal data shows that Randomize.net is highly regarded by our clients for its user-friendly interface and comprehensive features tailored for clinical trials. Clients appreciate the platform’s intuitive design, which simplifies the setup of randomization applications, allowing trials to be configured in just minutes.

Key features that our clients find particularly beneficial include:

• Unlimited Trial Parameters: The platform offers unlimited trial duration, number of subjects, clinical sites, treatment arms, and stratification variables, all for a one-time fee.

• Double-Blinded Trials Support: Full support for double-blinded trials, including kit management, kit replacement, and emergency unblinding, ensures the integrity of the study.

• Advanced Randomization Algorithms: Clients value the support for permuted blocked stratification, minimization, and simple randomization algorithms, which enhance the robustness of trial designs.

• Real-Time Reporting: The ability to view and download real-time reports allows for efficient monitoring and decision-making throughout the trial process.

• User Management: The platform enables the creation of multiple Coordinating Center users, each with specific roles such as Administrator, Auditor, or Kit Administrator, facilitating effective team collaboration.

Security is a top priority for our clients, and Randomize.net’s compliance with FDA 21 CFR Part 11 provides confidence in its data integrity and security measures. Additionally, the platform’s Web Service API allows for seamless integration with other applications, enhancing workflow efficiency.

In terms of pricing, clients find the one-time activation fee structure appealing. For academic or hospital-funded trials, the fee is $2,500 per trial, while private sector-funded trials are priced at $4,500 per trial. This pricing model includes unlimited support and access to all features, offering significant value.

Overall, our clients report that Randomize.net effectively streamlines the randomization process in clinical trials, combining ease of use with comprehensive functionality and robust security measures.